Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | STAT3 | P40763 | 1/20 | 0.59 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.55 |
| ▸ | GLA | P06280 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | MBNL1 | Q9NR56 | 1/20 | 0.49 |
| ▸ | NQO2 | P16083 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.45 |
| ▸ | TTR | P02766 | 1/20 | 0.44 |
| ▸ | MIF | P14174 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31122649 | 0.98 | ALDH1A1 (0.57) | ALDH1A1KDM4EHPGDGAATDP1 | |
| SCHEMBL7184557 | 0.98 | ALDH1A1 (0.57) | ALDH1A1KDM4EHPGDGAATDP1 | |
| SCHEMBL30486684 | 0.77 | ALDH1A1 (0.63) | ALDH1A1KDM4EHPGDGAATDP1 | |
| SCHEMBL7159163 | 0.77 | ALDH1A1 (0.63) | ALDH1A1KDM4EHPGDGAATDP1 | |
| SCHEMBL22326435 | 0.77 | PDE10A (0.77) | ALDH1A1KDM4EHPGDGAATDP1 | |
| SCHEMBL38652592 | 0.77 | ALDH1A1 (0.63) | ALDH1A1KDM4EHPGDGAATDP1 | |
| SCHEMBL422035 | 0.77 | ALDH1A1 (0.63) | ALDH1A1KDM4EHPGDGAATDP1 | |
| SCHEMBL209889 | 0.77 | ALDH1A1 (0.63) | ALDH1A1KDM4EHPGDGAATDP1 | |
| SCHEMBL8340066 | 0.77 | CYP1A2 (0.50) | ALDH1A1KDM4EHPGDGAATDP1 | |
| Hydrochloric Acid SCHEMBL7361242 | 0.76 | ALDH1A1 (0.61) | ALDH1A1KDM4EHPGDGAATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111704633-A | Mo catalyst and application thereof in preparation of 9, 10-epoxy-1, 5-cyclododecadiene | 万华化学集团股份有限公司 | 2020-09-25 | — | — | CN | claimed |
| US-8623519-B2 | Red phosphorescent compound and organic electroluminescent device using the same | LG DISPLAY CO., LTD. (KR) | 2014-01-07 | — | — | US | claimed |
| EP-0140347-A2 | Fluorescent corrosive fluoride solution | UNION CARBIDE CORPORATION (US) | 1985-05-08 | — | — | EP | claimed |
| CN-117986220-A | Method for preparing substituted chromanone derivative | 杭州杜易科技有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-114222734-B | Method for preparing substituted chromanone derivative | 杭州杜易科技有限公司 | 2023-12-08 | — | — | CN | disclosed |
| EP-4227304-A2 | THIADIAZOLE ANALOGS AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH A DEFICIENCY OF SMN MOTOR NEURONS | Novartis AG (CH) | 2023-08-16 | — | — | EP | disclosed |
| US-20230027684-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2023-01-26 | — | — | US | disclosed |
| CN-114222734-A | Method for preparing substituted chromanone derivative | 杭州杜易科技有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-113613732-A | Liquid hair dye composition | 花王株式会社 | 2021-11-05 | — | — | CN | disclosed |
| EP-3736271-A1 | THIADIAZOLE ANALOGS AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH A DEFICIENCY OF SMN MOTOR NEURONS | Novartis AG (CH) | 2020-11-11 | — | — | EP | disclosed |
| CN-111704633-A | Mo catalyst and application thereof in preparation of 9, 10-epoxy-1, 5-cyclododecadiene | 万华化学集团股份有限公司 | 2020-09-25 | — | — | CN | disclosed |
| US-20040247937-A1 | Organic electroluminescent devices with a doped co-host emitter | E-RAY OPTELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2004-12-09 | — | — | US | disclosed |
| US-20040126439-A1 | Composition useful as hepatoprotectants comprising extract of plant cryptolepis buchanani and a method thereof | OAZI GHULAM NABI | 2004-07-01 | — | — | US | disclosed |
| US-6686375-B2 | Composition useful as hepatoprotectants comprising extract of plant Cryptolepis buchanani and a method thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-02-03 | — | — | US | disclosed |
| US-20030185906-A1 | Composition useful as hepatoprotectants comprising extract of plant Cryptolepis Buchanani and a method thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-10-02 | — | — | US | disclosed |
| US-6548086-B1 | Controlling immunology response; administering plant extract;side effect reduction | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-04-15 | — | — | US | disclosed |
| EP-1121385-A1 | ELASTOMERIC POLYMER VEHICLE PARTS HAVING IMPROVED LOW-TEMPERATURE COMPRESSION SET | ExxonMobil Chemical Patents Inc. (US) | 2001-08-08 | — | — | EP | disclosed |
| WO-2000022015-A9 | ELASTOMERIC POLYMER VEHICLE PARTS HAVING IMPROVED LOW-TEMPERATURE COMPRESSION SET | EXXON CHEMICAL PATENTS INC (US) | 2000-10-12 | — | — | WO | disclosed |
| WO-2000022014-A1 | ELASTOMERIC POLYMER VEHICLE PARTS HAVING IMPROVED LOW TEMPERATURE COMPRESSION SET | EXXON CHEMICAL PATENTS INC. (US) | 2000-04-20 | — | — | WO | disclosed |
| WO-2000022015-A1 | ELASTOMERIC POLYMER VEHICLE PARTS HAVING IMPROVED LOW-TEMPERATURE COMPRESSION SET | EXXON CHEMICAL PATENTS INC. (US) | 2000-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027684-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | RBM17, SF3B1, SF3B5 | ALDH1A1 3964/4885KDM4E 2544/4885HPGD 3316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.